Semaglutide GLP-1 helps individuals achieve real, transformative changes to their health and lifestyle
The addition resulted in effective glycemic control (between-treatment difference in least squares mean change from baseline, -0.70%) and the changes were well tolerated, with no increased risk of hypoglycemia compared with the placebo (2 vs
It is well-known that GLP-1 is strongly secreted in response to the intake of macronutrients, including carbohydrates, proteins, and lipids
Check the availability updates page for the latest status
Although adverse events were mentioned in some trials, most of them were not reported
Buettner added that he has never seen the condition manifest in a patient, reiterating that these are very rare complications. He advised that anyone noticing changes in their vision while on these medications should stop taking them and contact a doctor immediately